Literature DB >> 7325627

Influence of age on tobramycin pharmacokinetics in patients with normal renal function.

L A Bauer, R A Blouin.   

Abstract

The influence of age on tobramycin half-life, volume of distribution, and clearance was examined in 77 patients with infections due to gram-negative bacteria. All patients had normal renal function and hematocrits, were within 20% of their ideal body weight, did not receive penicillin antibiotics concurrently, and had a fever. Twenty-five patients were between 20 and 39 years of age, 23 patients were 40 to 59 years old, and 29 patients were in the age group 60 to 79 years. The mean half-lives were 2.3, 2.2, and 2.4 h, respectively, for the three age groupings. The average clearance and volume of distribution terms were, respectively, 1.34 ml/min per kg and 0.25 liter/kg for the younger group, 1.44 ml/min per kg and 0.26 liter/kg for the middle age group, and 1.25 ml/min per kg and 0.25 liter/kg for the older group. There was no significant difference among the three groups for any of the parameters (P less than 0.05, analysis of variance). Correlation coefficients determined from individual plots of the three pharmacokinetic parameters versus age revealed no correlation between any parameter and age. Forty-five percent of the patients required doses greater than the recommended maximum (5 mg/kg per day) to achieve desired steady-state concentrations. Since tobramycin pharmacokinetics do not change as age increased, doses do not need to be arbitrarily changed in older patients with normal renal function.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7325627      PMCID: PMC181756          DOI: 10.1128/AAC.20.5.587

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  12 in total

1.  Gentamicin blood levels: a guide to nephrotoxicity.

Authors:  J G Dahlgren; E T Anderson; W L Hewitt
Journal:  Antimicrob Agents Chemother       Date:  1975-07       Impact factor: 5.191

2.  Pharmacokinetics of dosing regimens which utilize multiple intravenous infusions: gentamicin in burn patients.

Authors:  R J Sawchuk; D E Zaske
Journal:  J Pharmacokinet Biopharm       Date:  1976-04

3.  Correlation of serum creatinine concentration and gentamicin half-life.

Authors:  R E Cutler; A M Gyselynck; W P Fleet; A W Forrey
Journal:  JAMA       Date:  1972-02-21       Impact factor: 56.272

4.  Letter: Creatinine clearance and age.

Authors:  M H Gault; D W Cockcroft
Journal:  Lancet       Date:  1975-09-27       Impact factor: 79.321

5.  Gentamicin sulfate pharmacokinetics: lower levels of gentamicin in blood during fever.

Authors:  J E Pennington; D C Dale; H Y Reynolds; J D MacLowry
Journal:  J Infect Dis       Date:  1975-09       Impact factor: 5.226

6.  Tobramycin pharmacokinetics in morbidly obese patients.

Authors:  R A Blouin; H J Mann; W O Griffen; L A Bauer; K E Record
Journal:  Clin Pharmacol Ther       Date:  1979-10       Impact factor: 6.875

7.  Predictability of blood levels of gentamicin in man.

Authors:  M Barza; R B Brown; D Shen; M Gibaldi; L Weinstein
Journal:  J Infect Dis       Date:  1975-08       Impact factor: 5.226

8.  Kinetic model for gentamicin dosing with the use of individual patient parameters.

Authors:  R J Sawchuk; D E Zaske; R J Cipolle; W A Wargin; R G Strate
Journal:  Clin Pharmacol Ther       Date:  1977-03       Impact factor: 6.875

9.  Gentamicin dosage requirements: wide interpatient variations in 242 surgery patients with normal renal function.

Authors:  D E Zaske; R J Cipolle; R J Strate
Journal:  Surgery       Date:  1980-02       Impact factor: 3.982

10.  Increased gentamicin dosage requirements: rapid elimination in 249 gynecology patients.

Authors:  D E Zaske; R J Cipolle; R G Strate; W F Dickes
Journal:  Am J Obstet Gynecol       Date:  1981-04-15       Impact factor: 8.661

View more
  5 in total

Review 1.  Use of aminoglycosides in elderly patients. Pharmacokinetic and clinical considerations.

Authors:  K Mörike; M Schwab; U Klotz
Journal:  Drugs Aging       Date:  1997-04       Impact factor: 3.923

Review 2.  Antibiotic pharmacokinetics in cystic fibrosis. Differences and clinical significance.

Authors:  R de Groot; A L Smith
Journal:  Clin Pharmacokinet       Date:  1987-10       Impact factor: 6.447

Review 3.  Clinical pharmacokinetics of antibiotics in patients with impaired renal function.

Authors:  W L St Peter; K A Redic-Kill; C E Halstenson
Journal:  Clin Pharmacokinet       Date:  1992-03       Impact factor: 6.447

4.  Influence of age on amikacin pharmacokinetics in patients without renal disease. Comparison with gentamicin and tobramycin.

Authors:  L A Bauer; R A Blouin
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

5.  Pharmacokinetics of tobramycin and gentamicin in abusers of intravenous drugs.

Authors:  C H King; R J Creger; J J Ellner
Journal:  Antimicrob Agents Chemother       Date:  1985-03       Impact factor: 5.191

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.